Ruolan Han

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. pmc CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo
    Joerg Dietrich
    Department of Biomedical Genetics, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA
    J Biol 5:22. 2006
  2. pmc Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system
    Ruolan Han
    Department of Biomedical Genetics and University of Rochester Stem Cell and Regenerative Medicine Institute, University of Rochester Medical Center, Elmwood Avenue, Rochester, NY 14642, USA
    J Biol 7:12. 2008

Detail Information

Publications2

  1. pmc CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo
    Joerg Dietrich
    Department of Biomedical Genetics, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA
    J Biol 5:22. 2006
    ..The underlying cellular basis for these adverse effects is poorly understood...
  2. pmc Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system
    Ruolan Han
    Department of Biomedical Genetics and University of Rochester Stem Cell and Regenerative Medicine Institute, University of Rochester Medical Center, Elmwood Avenue, Rochester, NY 14642, USA
    J Biol 7:12. 2008
    ..Nor are there any animal models that could enable the study of this important problem...